BTBD11
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
160314copy number gainGRCh38/hg38 12q23.3(chr12:107392918-107670894)x3-1-12107786695108064671nana
160314copy number gainGRCh38/hg38 12q23.3(chr12:107392918-107670894)x3-1-12107392918107670894nana
160314copy number gainGRCh38/hg38 12q23.3(chr12:107392918-107670894)x3-1-12106310825106588801nana
220998single nucleotide variantNM_001018072.1(BTBD11):c.148A>G (p.Ser50Gly)200629571MedGen:C0376358,OMIM:176807,SNOMED CT:C037635812107319088107319088AG
220998single nucleotide variantNM_001018072.1(BTBD11):c.148A>G (p.Ser50Gly)200629571MedGen:C0376358,OMIM:176807,SNOMED CT:C037635812107712865107712865AG
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
12107751511rs4964569GArs49645696.38E-05NICOTINE|BUPROPIONNICOTINIC AGONISTS|ANTIDEPRESSIVE AGENTS, SECOND-GENERATIONSmoking cessationHPOID:0000707DOID:0050742GintronGWASdb_drug
12107772248rs1426467CGrs14264676.49E-05NICOTINE|BUPROPIONNICOTINIC AGONISTS|ANTIDEPRESSIVE AGENTS, SECOND-GENERATIONSmoking cessationHPOID:0000707DOID:0050742CintronGWASdb_drug
12107830356rs7957618CTrs79576181.72E-04NICOTINE|BUPROPIONNICOTINIC AGONISTS|ANTIDEPRESSIVE AGENTS, SECOND-GENERATIONSmoking cessationHPOID:0000707DOID:0050742TintronGWASdb_drug
12107847588rs10861740GCrs108617408.40E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytidine analogues (gemcitabine)HPOID:0002664DOID:162GintronGWASdb_drug
12107861624rs10778561TCrs107785611.91E-05NICOTINE|BUPROPIONNICOTINIC AGONISTS|ANTIDEPRESSIVE AGENTS, SECOND-GENERATIONSmoking cessationHPOID:0000707DOID:0050742CintronGWASdb_drug
12107723717rs10861724GArs108617247.09E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
12107728676rs759564GArs7595649.97E-04Alzheimer's diseaseHPOID:0002511DOID:10652GintronGWASdb_trait
12107732227rs7953431TGrs79534316.46E-05Major depressive disorderHPOID:0000716DOID:1470GintronGWASdb_trait
12107743775rs1863538ACrs18635383.32E-05Major depressive disorderHPOID:0000716DOID:1470GintronGWASdb_trait
12107750777rs4964213TCrs49642131.30E-05Amyotrophic Lateral SclerosisHPOID:0007354DOID:332CintronGWASdb_trait
12107751511rs4964569GArs49645696.38E-05Smoking cessationHPOID:0000707DOID:0050742GintronGWASdb_trait
12107767730rs11113292GArs111132925.39E-05Major depressive disorderHPOID:0000716DOID:1470GintronGWASdb_trait
12107771447rs7968306TCrs79683065.53E-04Multiple complex diseasesHPOID:0000118NAT,CintronGWASdb_trait
12107772248rs1426467CGrs14264676.49E-05Smoking cessationHPOID:0000707DOID:0050742CintronGWASdb_trait
12107772542rs10861732GArs108617326.96E-04Amyotrophic Lateral SclerosisHPOID:0007354DOID:332GintronGWASdb_trait
12107772567rs1426466TCrs14264669.49E-05Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
12107776025rs10861733AGrs108617338.96E-04Alzheimer's diseaseHPOID:0002511DOID:10652AintronGWASdb_trait
12107779889rs7302236AGrs73022364.12E-04Amyotrophic Lateral SclerosisHPOID:0007354DOID:332GintronGWASdb_trait
12107785498rs1895990TCrs18959908.26E-06Serum metabolitesHPOID:0011111NAGintronGWASdb_trait
12107788365rs10128899GArs101288993.02E-04Rheumatoid arthritisHPOID:0001370DOID:7148GintronGWASdb_trait
12107790783rs10778554ACrs107785543.09E-04Rheumatoid arthritisHPOID:0001370DOID:7148AintronGWASdb_trait
12107801897rs749137AGrs7491378.68E-05Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
12107814757rs11113318AGrs111133185.00E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
12107830356rs7957618CTrs79576181.72E-04Smoking cessationHPOID:0000707DOID:0050742TintronGWASdb_trait
12107842863rs17039297CTrs170392977.32E-04Multiple complex diseasesHPOID:0000118NACintronGWASdb_trait
12107847588rs10861740GCrs108617408.40E-04Response to cytidine analogues (gemcitabine)HPOID:0002664DOID:162GintronGWASdb_trait
12107861624rs10778561TCrs107785611.91E-05Smoking cessationHPOID:0000707DOID:0050742CintronGWASdb_trait
12107861624rs10778561TCrs107785611.48E-05Parent of origin effect on language impairment (maternal)HPOID:0002463DOID:93CintronGWASdb_trait
12107879066rs11113349CTrs111133491.16E-05Response to methotrexate in juvenile idiopathic arthritisHPOID:0005681DOID:676CintronGWASdb_trait
12107922099rs11113379GArs111133799.61E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
12107942604rs17756735GArs177567353.64E-06C-reactive proteinHPOID:0010876DOID:14221|DOID:9352|DOID:10763|DOID:5844GintronGWASdb_trait
12107956249rs182722816GTrs1827228167.00E-07AsthmaHPOID:0002099DOID:2841GintronGWASdb_trait
12107979573rs11832945TArs118329454.06E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
12107979941rs957626CArs9576269.20E-05Response to lithium treatment in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
12107987966rs4528429GArs45284296.22E-05Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
12108040682rs7309802GTrs73098027.05E-04Obesity (extreme)HPOID:0001513DOID:9970GintronGWASdb_trait
12108045139rs2241187TGrs22411873.96E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312AintronGWASdb_trait
12108045139rs2241187TGrs22411875.45E-05Obesity (extreme)HPOID:0001513DOID:9970AintronGWASdb_trait